HOME > BUSINESS
BUSINESS
- Biogen Japan Chairman Torii to Resign Sept. 30
September 26, 2019
- Chugai’s Comprehensive Genomic Profiling Test Approved for Companion Diagnostic for Lynparza
September 26, 2019
- Mylan EPD Submits Clinical Trial Application in Japan for PIII Study of Eyedrop Therapy for Cystinosis
September 26, 2019
- Chinese Regulators Accept Tenelia for Review
September 25, 2019
- Astellas’ AML Drug Gets European Panel Backing
September 25, 2019
- Mylan to Distribute Eisai’s Cancer Treatment Halaven under Brand Name of Teceris in India
September 24, 2019
- Kyoto Univ. Spinout Boots Up to Develop iPSC-Based Kidney Therapy
September 24, 2019
- Mitsubishi Tanabe to Join Promotion for Santen’s Alesion Eye Drops
September 24, 2019
- Kissei Kicks Off Japan PIII for ITP Drug Fostamatinib
September 24, 2019
- SanBio’s Lead Cell Therapy Rides High with FDA’s RMAT Designation for Traumatic Brain Injury
September 20, 2019
- JCR Drops Temcell Submission for Epidermolysis Bullosa
September 20, 2019
- Kyowa Kirin to Keep Challenging to Boost Global Footprint: President
September 20, 2019
- Japan’s 1st Forteo Biosimilar Nears Market, Mochida Looks at Billion-Yen Sales
September 19, 2019
- US FDA Gives 1st Nod for Lenvima/Keytruda Combo as 2nd-Line Therapy for Endometrial Carcinoma
September 19, 2019
- GSK Launches Clinical Research of Platform for Prevention of COPD Exacerbations
September 19, 2019
- Luring Big Pharma with GPCR Work, Sosei Heptares Treads Its Own Path to Pursue Small Molecule Targets
September 18, 2019
- No Major Impact on Shionogi, Eisai from Purdue’s Bankruptcy Filing
September 18, 2019
- Fujifilm Grabs Rights to Cynata’s Cell Therapy for GVHD
September 18, 2019
- Enfortumab Vedotin Gets FDA Priority Review for Urothelial Cancer: Astellas/Seattle Genetics
September 18, 2019
- Mitsubishi Tanabe Grants Daiichi Sankyo Commercialization Rights for Edaravone in Brazil
September 18, 2019
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
